There is a pressing need to improve the understanding of safety issues during drug development and post-approval. Our interviewees this month explain their roles in efforts to enhance drug safety.

A multicenter study led by Cedars-Sinai created a database of adverse medication events—the fourth leading cause of death in ...

A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk factor in the blood. The drug, made by Eli Lilly and called lepodisiran, lowered ...

This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies of approved drugs with hidden risks.